Second malignancies in patients with essential thrombocythaemia.
Randi
M L
ML
Fabris
F
F
Girolami
A
A
D000328:Adult; D000368:Aged; D000970:Antineoplastic Agents / Q000009:adverse effects*; D002066:Busulfan / Q000009:adverse effects; D005260:Female; D005500:Follow-Up Studies; D006801:Humans; D006918:Hydroxyurea / Q000009:adverse effects*; D008297:Male; D008875:Middle Aged; D016609:Neoplasms, Second Primary / Q000209:etiology*; D013920:Thrombocythemia, Essential / Q000188:drug therapy*
D000970:Antineoplastic Agents; D002066:Busulfan; D006918:Hydroxyurea